Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
2023-10-04 04:25
China Review Studio and Chinese Red Cross Foundation Release "Generation Vax" Documentary for Broadcast Internationally
2023-10-02 15:00
Everest Medicines Announces Approval of XERAVA® in Taiwan for the Treatment of Complicated Intra-Abdominal Infections in Adult Patients
2023-09-28 07:38
Global Times: China-Africa medical cooperation broadens under BRI
2023-09-04 08:43
Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report and latest progress
2023-08-28 11:08
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics
2023-08-25 15:14
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
2023-08-22 22:00
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI)
2023-08-15 20:19
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan
2023-08-14 21:30
Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong, For Adults Aged 18 Years or Older[1]
2023-08-10 14:15
AI-based wastewater sampling predicts COVID pressure on hospitals
2023-08-07 21:13
AmCham South China Study - Business Confidence in China Rising, Increases in Investment Plans Observed
2023-08-02 09:00
World Hepatitis Alliance raise awareness of viral hepatitis on World Hepatitis Day as research shows hepatitis B and C cause significantly higher cancer risk than smoking a daily pack of cigarettes
2023-07-28 04:02
Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress
2023-07-27 10:57
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent
2023-07-21 16:47
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure
2023-07-06 07:25
Brii Biosciences Provides Latest Clinical Development and Corporate Updates
2023-07-06 07:19
BGI CEO Yin Ye Advocates for Global Technology Sharing
2023-07-05 14:17
New Survey Reveals Insights on Singapore Workers' Preparedness for Digital Transformation
2023-07-03 07:45
Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective
2023-06-29 00:00
1
2
3
4
5
6
91